Statement on Second Circuit Order Upholding “Pharma Bro” Martin Shkreli’s Lifetime Ban

Excerpt:  “Today, the United States Court of Appeals for the Second Circuit affirmed a district court ruling which ordered ‘Pharma Bro’ Martin Shkreli to face a lifetime ban from participating in the pharmaceutical industry and found Shkreli liable for $64.6 million in disgorgement for his role in orchestrating an illegal anticompetitive scheme. … In January 2022, the U.S. District Court for the Southern District of New York held that Shkreli organized an illegal anticompetitive scheme to perpetuate a monopoly for the life-saving drug Daraprim, the gold-standard treatment for a rare, potentially fatal parasitic infection known as toxoplasmosis.”